There is a very significant-sized graveyard for P38 inhibitors that still has space for new entrants. :)
Yeah I don't really assign much, if any, value to ARRY-797 and am just playing the "would love to be surprised" game. They already abandoned development on the drug once before (guessing it was resource related and fact that program lower priority) and only recently re-started development.
Market Data 
Markets 
AI
